The present study showed the involvement of MCT1 in the tumorigenesis and progression of RB, as the intravitreal injection of MCT1 inhibitors effectively reduces intraocular tumor burden in nude mouse orthotopic transplantation models. Here, SLC16A1 is linked to retinoblastoma.